Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Movement Disorders : Official Journal of the Movement Disorder Society|October 27, 2023
A Randomized Phase 3 Study Comparing P2B001 to its Components (Low-Dose Extended-Release Rasagiline and Pramipexole) and to Optimized Doses of Marketed Extended-Release Pramipexole in Early Parkinson's DiseaseC Warren Olanow, Robert A Hauser, Daniel J Burdick, et al.
Parkinsonism & Related Disorders|May 2, 2021
Efficacy results of pimavanserin from a multi-center, open-label extension study in Parkinson's disease psychosis patientsStuart H Isaacson, Clive G Ballard, David L Kreitzman, et al.
Parkinsonism & Related Disorders|July 27, 2020
Long-term evaluation of open-label pimavanserin safety and tolerability in Parkinson's disease psychosisClive G Ballard, David L Kreitzman, Stuart Isaacson, et al.
Movement Disorders Clinical Practice|April 18, 2023
Expert Consensus on the Use of <i>On</i>-Demand Treatments for OFF Episodes in Parkinson's Disease: A Modified Delphi PanelStuart H Isaacson, Madhureeta Achari, Roongroj Bhidayasiri, et al.
JAMA Neurology|October 20, 2025
Transcutaneous Peripheral Nerve Stimulation for Essential Tremor: A Randomized Clinical TrialWilliam G Ondo, Wen Lv, Xiaodong Zhu, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 4, 2017
A randomized trial of a low-dose Rasagiline and Pramipexole combination (P2B001) in early Parkinson's diseaseC Warren Olanow, Karl Kieburtz, Mika Leinonen, et al.
Physical Review Letters|November 5, 2004
Depth-controlled beta-NMR of 8Li in a thin silver filmG D Morris, W A Macfarlane, K H Chow, et al.
Pageof 5